[HTML][HTML] Auranofin: Past to Present, and repurposing
M Yamashita - International Immunopharmacology, 2021 - Elsevier
Auranofin (AF), a gold compound, has been used to treat rheumatoid arthritis (RA) for more
than 40 years; however, its mechanism of action remains unknown. We revealed that AF …
than 40 years; however, its mechanism of action remains unknown. We revealed that AF …
The lung microbiome in COPD and lung cancer: Exploring the potential of metal-based drugs
M O'Shaughnessy, O Sheils, AM Baird - International Journal of …, 2023 - mdpi.com
Chronic obstructive pulmonary disease (COPD) and lung cancer 17 are two of the most
prevalent and debilitating respiratory diseases worldwide, both associated with high …
prevalent and debilitating respiratory diseases worldwide, both associated with high …
Thioredoxin reductase is a valid target for antimicrobial therapeutic development against gram-positive bacteria
LO Felix, E Mylonakis, BB Fuchs - Frontiers in Microbiology, 2021 - frontiersin.org
There is a drought of new antibacterial compounds that exploit novel targets. Thioredoxin
reductase (TrxR) from the Gram-positive bacterial antioxidant thioredoxin system has …
reductase (TrxR) from the Gram-positive bacterial antioxidant thioredoxin system has …
In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci
Vancomycin-resistant enterococci (VRE) are a serious public health threat and a leading
cause of healthcare-associated infections. Bacterial resistance to antibiotics recommended …
cause of healthcare-associated infections. Bacterial resistance to antibiotics recommended …
In Vivo Antibacterial Activity of Acetazolamide
Vancomycin-resistant enterococci (VRE) represent a major public health threat that requires
the development of new therapeutics. In the present study, acetazolamide (AZM) was …
the development of new therapeutics. In the present study, acetazolamide (AZM) was …
In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection
Gonococcal infections represent an urgent public health threat worldwide due to the
increasing incidence of infections that has been accompanied by an increase in bacterial …
increasing incidence of infections that has been accompanied by an increase in bacterial …
Inhibition of selenoprotein synthesis is not the mechanism by which auranofin inhibits growth of Clostridioides difficile
MA Johnstone, MA Holman, WT Self - Scientific Reports, 2023 - nature.com
Clostridioides difficile infections (CDIs) are responsible for a significant number of antibiotic-
associated diarrheal cases. The standard-of-care antibiotics for C. difficile are limited to …
associated diarrheal cases. The standard-of-care antibiotics for C. difficile are limited to …
Targeting Clostridioides difficile: New uses for old drugs
J Chen, Y Li, S Wang, H Zhang, Y Du, Q Wu… - Drug Discovery …, 2022 - Elsevier
Clostridioides difficile bacteria can cause life-threatening diarrhea and colitis owing to
limited treatment options and unacceptably high recurrence rates among infected patients …
limited treatment options and unacceptably high recurrence rates among infected patients …
Exploring novel aryl/heteroaryl-isosteres of phenylthiazole against multidrug-resistant bacteria
Antimicrobial resistance has become a concern as a worldwide threat. A novel scaffold of
phenylthiazoles was recently evaluated against multidrug-resistant Staphylococci to control …
phenylthiazoles was recently evaluated against multidrug-resistant Staphylococci to control …
New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation
T Bratkovič, A Zahirović, M Bizjak, M Rupnik… - Gut …, 2024 - Taylor & Francis
Clostridioides difficile causes a range of debilitating intestinal symptoms that may be fatal. It
is particularly problematic as a hospital-acquired infection, causing significant costs to the …
is particularly problematic as a hospital-acquired infection, causing significant costs to the …